Table 7.

Inclusivity in relation to consideration of homelessness and contextual factors

Guideline	Does the guideline mention that concurrent problems can increase risk of self-harm, suicide, violence, injury or offending behaviour?	Is the risk of criminal justice system/offending/prison for those affected mentioned?	Does the guideline recommend providing health care for prison offender in rehabilitation centre	Is the risk of homelessness for those affected mentioned?	Does the guideline provide suggestions for healthcare professionals to refer patients to housing assistance or homelessness services if patients are found at risk of homelessness	Does the screening mentions patient history of sexual or other forms of abuse?	Is there mention of or consideration about stigma and discrimination in healthcare setting?	Does the guideline mention the importance of working with voluntary, charity or No?
NICE 2011 (coexisting disorders) [37]	Yes	Yes	Yes, in case of diverted treatment	Yes	Yes	Yes	Yes	Yes
NICE 2016 (coexisting disorders) [38]	Yes	Yes	No	Yes	Yes	No	Yes	Yes
Australian government 2016 [39]	Yes	No	No	Yes	No	Yes	Yes	No
SIGN 2013 [47]	Yes	No	No	Yes	Yes	No	No	No
NICE 2014 [48]	No	No	No	No	No	No	Yes	Yes
WFSBP 2015 [49]	Yes	No	No	Yes	Yes	No	No	No
RANZCP 2016 [50]	Yes	Yes	No	Yes	Yes	No	Yes	Yes
BAP 2019 [51]	No	No	No	No	No	No	No	No
APA 2020 [52]	Yes	No	No	Yes	Yes	Yes	No	No
VA/DoD 2010 [53]	Yes	No	No	No	No	Yes, but as risk factor for suicide in patients with bipolar disorder	No	No
Singapore MOH 2011 [54]	Yes	No	No	No	No	No	No	No
NICE 2014 [55]	Yes	No	No	No	No	Yes	Yes	No
BAP 2016 [56]	Yes	No	No	No	No	No	No	No
CANMAT and ISBD 2018 [57]	Yes	No	No	No	No	No	No	No
BAP 2012 [40]	No	No	No	No	No	No	No	No
WFSBP 2017 [41]	Yes	No	No	No	No	No	No	No
gov.uk 2017 [42]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
DGPPN and DG-Sucht 2017 [43]	No	No	No	No	No	No	No	No
NICE 2011 [44]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes
APA 2018 [45]	Yes	No	No	No	No	No	No	No
ASAM 2015 [46]	Yes	Yes	No	No	No	No	No	No

AOD Alcohol and other drug, APA American Psychiatric Association, ASAM American society of addiction medicine, AUD alcohol use disorder, BAP British Association of psychopharmacology, CANMAT and ISBD Canadian Network for Mood and Anxiety Treatments and International Society for Bipolar Disorders, gov.UK United Kingdom guidelines on clinical management, DGPPN and DG-Sucht German Association for Psychiatry, Psychotherapy, and Psychosomatics and the German Association for Addiction Research and Therapy, NICE National Institute for Health and Care Excellence, RANZCP Royal Australian and New Zealand College of Psychiatrists, SIGN Scottish Intercollegiate Guidelines Network, Singapore MOH Singapore Ministry of Health, SMI Severe mental illness, SUD Substance use disorder, UK United Kingdom, US United States, VA/DoD Department of Veterans Affairs and The Department of Defense, WFSBP World Federation of Societies of Biological Psychiatry